cardiovascular disease

CRISPR’s cardio catch-all drives a biotech’s broad potential
Pharma Voice
Tue, 02/18/25 - 09:53 am
Scribe Therapeutics
CRISPR
cardiovascular disease
In the crowded cardio space, it’s David vs. Goliath for small biotechs
Pharma Voice
Tue, 02/11/25 - 11:12 am
cardiovascular disease
Merck
Winrevair
Tourmaline Bio
pacibekitug
XyloCor Therapeutics Raises $67.5 Million in Series B Financing to Advance Clinical Development of Novel Gene Therapy in Cardiovascular Disease
BioSpace
Tue, 01/7/25 - 11:33 am
XyloCor
funding
cardiovascular disease
10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thu, 01/2/25 - 11:42 am
clinical trials
Eli Lilly
cardiovascular disease
Arvinas
protein degradation
Vera Therapeutics
IgA nephropathy
Novarts
pelacarsen
Entyvio
IBD
Novo Nordisk
Alzheimer's disease
Beam Therapeutics
sickle cell disease
COMPASS Pathways
psychedelics
Moderna Therapeutics
Verve Therapeutics
high cholesterol
Novo’s GLP-1 Wegovy could improve heart health for millions more than previously thought, AI study finds
Pharma Voice
Mon, 10/7/24 - 11:23 am
Novo Nordisk
Wegovy
cardiovascular disease
artificial intelligence
Dandelion Health
J&J to shutter cardiovascular, metabolic drug unit
Seeking Alpha
Thu, 09/26/24 - 03:15 pm
JNJ
layoffs
restructuring
cardiovascular disease
metabolic diseases
Gene therapy biotech Medera looks back to SPAC as way to go public
Fierce Biotech
Thu, 09/5/24 - 11:27 am
Medera
SPACs
gene therapy
cardiovascular disease
Bayer’s kidney disease drug Kerendia reduces cardiovascular risk by 16%
BioSpace
Tue, 09/3/24 - 11:31 am
Bayer
Kerendia
cardiovascular disease
heart failure
clinical trials
Novo builds heart failure case for semaglutide
BioPharma Dive
Fri, 08/30/24 - 11:31 am
Novo Nordisk
obesity
semaglutide
cardiovascular disease
Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually: Study
BioSpace
Tue, 08/27/24 - 11:32 am
Novo Nordisk
cardiovascular disease
Medicare
semaglutide
Wegovy
Ozempic
Arrowhead axes heart disease drug, goes all in on another as pipeline progress drives costs up
Fierce Biotech
Wed, 06/26/24 - 10:05 am
Arrowhead Pharmaceuticals
RNAi
zodasiran
plozasiran
cardiovascular disease
Statins for heart disease prevention could be recommended for far fewer Americans if new risk equation is adopted
Medical Xpress
Wed, 06/12/24 - 11:15 am
statins
cholesterol
cardiovascular disease
Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset
Fierce Biotech
Wed, 05/22/24 - 11:31 am
Boehringer Ingelheim
OSE Immunotherapeutics
cardiovascular disease
solid tumors
BMS, Avidity add another link to cardiovascular partnership with $100M expansion
Fierce Biotech
Tue, 11/28/23 - 10:29 am
Bristol Myers Squibb
Avidity Biosciences
R&D
cardiovascular disease
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Mon, 11/13/23 - 12:08 pm
Novo Nordisk
Wegovy
heart disease
cardiovascular disease
clinical trials
AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year
Pharmaphorum
Mon, 11/13/23 - 10:03 am
Eli Lilly
AHA
siRNA
lipoprotein(a)
cardiovascular disease
lepodisiran
Wegovy cuts risk of heart attacks in milestone cardiovascular trial
Stat
Sun, 11/12/23 - 09:32 pm
Wegovy
Novo Nordisk
clinical trials
cardiovascular disease
Merck keeps pumping up sotatercept, posting fresh data ahead of FDA approval ruling
Fierce Biotech
Mon, 09/11/23 - 12:35 pm
Merck
sotatercept
FDA
cardiovascular disease
Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death
Airfinity
Thu, 08/31/23 - 11:52 am
Novo Nordisk
Wegovy
Ozempic
cardiovascular disease
Amgen Presents Late-Breaking Phase 2 Olpasiran Data at ESC 2023
BioSpace
Mon, 08/28/23 - 12:02 pm
Amgen
cardiovascular disease
olpasiran
clinical trials

Pages